{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:36:41Z","timestamp":1788910601880,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/cgt.2017.4","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T11:20:51Z","timestamp":1488540051000},"page":"203-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity"],"prefix":"10.1038","volume":"24","author":[{"given":"A L","family":"Pop-Moldovan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N -M","family":"Trofenciuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"D\u0103r\u0103ban\u0163iu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Precup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Branea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Christodorescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pu\u015fchi\u0163\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"BFcgt20174_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cardfail.2011.01.011","volume":"17","author":"P Adamson","year":"2011","unstructured":"Adamson P, Zile M, Cho Y, Bennett T, Bourge R, Aaron M et al. Hemodynamic factors associated with acute decompensated heart failure: part 2\u2014use in automated detection. J Card Fail 2011; 17: 366\u2013373.","journal-title":"J Card Fail"},{"key":"BFcgt20174_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.bjc.6603640","volume":"96","author":"A Bruynzeel","year":"2007","unstructured":"Bruynzeel A, Abou El Hassan M, Schalkwijk C, Berkhof J, Bast A, Niessen H et al. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. Br J Cancer 2007; 96: 937\u2013943.","journal-title":"Br J Cancer"},{"key":"BFcgt20174_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.biopha.2004.12.003","volume":"59","author":"F Galetta","year":"2005","unstructured":"Galetta F, Franzoni F, Cervetti G, Cecconi N, Carpi A, Petrini M et al. Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients. Biomed Pharmacother 2005; 59: 541\u2013544.","journal-title":"Biomed Pharmacother"},{"key":"BFcgt20174_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1462-5822.2004.00489.x","volume":"7","author":"G Godaly","year":"2005","unstructured":"Godaly G, Young D . Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation. Cell Microbiol 2005; 7: 591\u2013601.","journal-title":"Cell Microbiol"},{"key":"BFcgt20174_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00520-007-0397-6","volume":"16","author":"R Jurcut","year":"2008","unstructured":"Jurcut R, Wildiers H, Ganame J, D\u2019hooge J, Paridaens R, Voigt J . Detection and monitoring of cardiotoxicity\u2014what does modern cardiology offer? Support Care Cancer 2008; 16: 437\u2013445.","journal-title":"Support Care Cancer"},{"key":"BFcgt20174_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/824135","volume":"2013","author":"K Komamura","year":"2013","unstructured":"Komamura K . Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure. Cardiol Res Pract 2013; 2013: 1\u20136.","journal-title":"Cardiol Res Pract"},{"key":"BFcgt20174_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1567-5769(02)00256-4","volume":"3","author":"S Lim","year":"2003","unstructured":"Lim S . Freund adjuvant induces TLR2 but not TLR4 expression in the liver of mice. Int Immunopharmacol 2003; 3: 115\u2013118.","journal-title":"Int Immunopharmacol"},{"key":"BFcgt20174_CR8","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","volume":"36","author":"M Malik","year":"2000","unstructured":"Malik M, Batchvarov V . Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749\u20131766.","journal-title":"J Am Coll Cardiol"},{"key":"BFcgt20174_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2169\/internalmedicine.43.379","volume":"43","author":"H Nakamae","year":"2004","unstructured":"Nakamae H, Tsumura K, Akahori M, Terada Y, Yamane T, Hatashi T et al. QT dispersion correlates with systolic rather than diastolic parameters in patients receiving anthracycline treatment. Intern Med 2004; 43: 379\u2013387.","journal-title":"Intern Med"},{"key":"BFcgt20174_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jacc.2010.02.070","volume":"56","author":"M Neizel","year":"2010","unstructured":"Neizel M, Korosoglou G, Lossnitzer D, K\u00fchl H, Hoffmann R, Ocklenburg C et al. Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up. J Am Coll Cardiol 2010; 56: 1056\u20131062.","journal-title":"J Am Coll Cardiol"},{"key":"BFcgt20174_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4250\/jcu.2011.19.4.169","volume":"19","author":"J Park","year":"2011","unstructured":"Park J, Marwick T . Use and limitations of E\/e' to assess left ventricular filling pressure by echocardiography. J Cardiovasc Ultrasound 2011; 19: 169.","journal-title":"J Cardiovasc Ultrasound"},{"key":"BFcgt20174_CR12","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.3748\/wjg.v21.i25.7730","volume":"21","author":"M Proen\u00e7a","year":"2015","unstructured":"Proen\u00e7a M . TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer. World J Gastroenterol 2015; 21: 7730.","journal-title":"World J Gastroenterol"},{"key":"BFcgt20174_CR13","doi-asserted-by":"crossref","unstructured":"Puppe J, van Ooyen D, Neise J, Thangarajah F, Eichler C, Pfister R et al. Prospective evaluation of cardiac safety in breast cancer patients after adjuvant treatment with epirubicin, cyclophosphamide, doxetaxel and with or without trastuzumab: A single center experience. Geburtshilfe Frauenheilkd 2015; 12.","DOI":"10.1055\/s-0035-1550557"},{"key":"BFcgt20174_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","volume":"36","author":"Y Shi","year":"2011","unstructured":"Shi Y, Moon M, Dawood S, McManus B, Liu P . Mechanisms and management of doxorubicin cardiotoxicity. Herz 2011; 36: 296\u2013305.","journal-title":"Herz"},{"key":"BFcgt20174_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10753-010-9245-9","volume":"34","author":"A Soylu","year":"2010","unstructured":"Soylu A, Ate\u015f H, Cing\u00f6z S, T\u00fcrkmen M, Demir B, Tunca M et al. TLR polymorphisms in FMF: association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) polymorphisms and myeloid cell TLR-2 and TLR-4 expression with the development of secondary amyloidosis in FMF. Inflammation 2010; 34: 379\u2013387.","journal-title":"Inflammation"},{"key":"BFcgt20174_CR16","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","volume":"97","author":"S Swain","year":"2003","unstructured":"Swain S, Whaley F, Ewer M . Congestive heart failure in patients treated with doxorubicin. Cancer 2003; 97: 2869\u20132879.","journal-title":"Cancer"},{"key":"BFcgt20174_CR17","doi-asserted-by":"crossref","unstructured":"Toll-like receptor-2 (TLR2); Toll-like receptor-4 (TLR4); interleukin-10 (IL-10). SciBX 2008; 1: 15.","DOI":"10.1038\/scibx.2008.41"},{"key":"BFcgt20174_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11764-011-0186-6","volume":"6","author":"E Vandecruys","year":"2011","unstructured":"Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B . Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood. J Cancer Surviv 2011; 6: 95\u2013101.","journal-title":"J Cancer Surviv"},{"key":"BFcgt20174_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cardfail.2011.01.010","volume":"17","author":"M Zile","year":"2011","unstructured":"Zile M, Adamson P, Cho Y, Bennett T, Bourge R, Aaron M et al. Hemodynamic factors associated with acute decompensated heart failure: part 1\u2014insights into pathophysiology. J Card Fail 2011; 17: 282\u2013291.","journal-title":"J Card Fail"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt20174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cgt.2017.4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T13:10:24Z","timestamp":1647954624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt20174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFcgt20174"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2017.4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]},"assertion":[{"value":"7 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}